ABCB1 and colorectal carcinoma: Similarly, Lei et al. also found that ABCB1 knockout could reverse 3H‐paclitaxel (PTX) resistance mediated by ABCB1 in SW620/Ad300 CRC cells by decreasing drug efflux.53